Media Kit

Scroll to top of page

Featured News

BlueRock Logo and Foundation Fighting Blindness Logo
Announcement
Ophthalmology

BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases

Announcement
Neurology
Parkinson's Disease

BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive trends at 18 months

Announcement
Ophthalmology

BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for treating Primary Photoreceptor Diseases from FUJIFILM Cellular Dynamics and Opsis Therapeutics

multicolor title graphic for cell & gene the podcast featuring BlueRock Therapeutics
Podcast

Cell & Gene The Podcast | Inside BlueRock Therapeutics' Parkinson's Disease Trial

See All

Media Library

Media Contact

Video

B-Roll: Lab 1

B-Roll: Lab 2

B-Roll: Lab 3

B-Roll: Lab 4

B-Roll: Lab 5

B-Roll: Lab 6

B-Roll: PSC-Derived Cardiomyocytes

Explore more with BlueRock

Cell Therapy

Our Programs

Our Pipeline

Careers